At a glance
- Originator Eli Lilly and Company
- Class Antihypertensives; Dihydropyridines; Small molecules
- Mechanism of Action Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Hypertension
Most Recent Events
- 05 Nov 2001 Discontinued-unspecified phase for Hypertension